Geneva, Switzerland

Maciej Wiznerowicz

USPTO Granted Patents = 3 


Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 29(Granted Patents)


Location History:

  • Geneva, CH (2007 - 2014)
  • Poznan, PL (2016)

Company Filing History:


Years Active: 2007-2016

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Maciej Wiznerowicz: A Pioneer in Gene Therapy Innovations**

Introduction

Maciej Wiznerowicz is an accomplished inventor based in Geneva, Switzerland. With a focus on lentiviral vector technology, he has made significant contributions to the field of human gene therapy. With three patents to his name, Wiznerowicz is recognized for his innovative approaches in medical science.

Latest Patents

One of Wiznerowicz's notable patents is titled "Methods and compositions relating to restricted expression lentiviral vectors and their applications." This invention presents HIV-derived lentivectors that are both safe and highly efficient for the expression of transgenes intended for human gene therapy. These lentiviral vectors are specifically designed for use in human hematopoietic progenitor cells, along with other blood cell derivatives. The vectors incorporate promoters that enhance expression specific to various cell types and tissues while ensuring biosafety through a self-inactivating configuration. Furthermore, the inclusion of transcription enhancing elements, such as the woodchuck hepatitis virus post-transcriptional regulatory element, ensures that there is no compromise on specificity or control provided by the promoters. These vectors serve as vital tools for treating inherited and acquired lympho-hematological disorders, as well as for gene therapies targeted at hematological cancers.

Career Highlights

Wiznerowicz has had an impactful career, working for leading institutions such as the Research Development Foundation and Institut Clayton De La Recherche. His research focuses on the innovative application of lentiviral vectors to improve gene therapy outcomes.

Collaborations

Throughout his career, Wiznerowicz has collaborated with notable figures including Didier Trono. These partnerships have further enriched his research and contributed to his patented innovations.

Conclusion

Maciej Wiznerowicz continues to be at the forefront of gene therapy research, driving innovations that have the potential to revolutionize treatment approaches for various hematological conditions. His work exemplifies the importance of combining scientific knowledge with practical application in the quest to find solutions to complex medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…